More than 235 smokers and former smokers have shared their experiences as THR Global’s
#WeAreTheEvidence campaign puts lived experience at the centre of the tobacco-harm-reduction conversation.
South Africa – September 2026: For years, the message to smokers has been straightforward: quit.
Yet the experiences of hundreds of smokers and former smokers suggest that walking away from
cigarettes is rarely that simple.
Insights from THR Global’s #WeAreTheEvidence campaign show that stress, anxiety and depression
are among the most cited reasons people start or continue smoking, with 32.8% of participants
identifying these factors in their personal journeys.
The finding points to a wider challenge in smoking cessation: wanting to quit does not always
translate into success. A South African study involving 18,208 adults found that 74.6% of current
combustible smokers had previously attempted to quit, while only 42.8% of those who had tried had
ever used a cessation aid.
That gap between intention and success is what THR Global is seeking to better understand.
Through #WeAreTheEvidence, the organisation has documented more than 235 first-hand accounts
from smokers and former smokers, capturing why people smoked, what made quitting difficult and
the different approaches they used to move away from cigarettes.
The stories show there is no single quitting experience.
Ndaphi began smoking in high school through peer influence and continued for 16 years. Over time,
he came to recognise the financial and personal impact of smoking, including the effect it had on
those closest to him, before eventually moving away from cigarettes through harm-reduction
alternatives.
Laksha’s experience was different. Nicotine pouches did not work for her because they failed to
replace the hand-to-mouth behaviour she associated with smoking. During her interview, she also
learned how her smoking had affected a friendship, with time together often interrupted by smoke
breaks.
These experiences illustrate why THR Global believes smoking cessation cannot be reduced to
willpower alone. Stress, behaviour, routines and personal circumstances can all shape a smoker’s
ability to quit.
The testimony archive also provides insight into what participants say helped them. Among THR
Global’s first 210 formal testimonials, 95.7% reported using vaping as part of their journey away
from cigarettes.
THR Global says these self-reported experiences should not replace clinical evidence but can add
important human context to it.
Recent research continues to examine the role of harm-reduction approaches in smoking cessation.
The Cochrane review on electronic cigarettes for smoking cessation found high-certainty evidence
Confidential – Not for Public Consumption or
Distribution
that nicotine-containing e-cigarettes increased quit rates compared with nicotine-replacement
therapy.
A separate 2026 review published in Addiction similarly found that estimates across multiple
systematic reviews consistently favoured nicotine-containing e-cigarettes over interventions
including nicotine-replacement therapy, non-nicotine e-cigarettes and other forms of support.
Mental wellbeing is another important part of the picture. A systematic review and meta-analysis
published in the British Medical Journal found that smoking cessation was associated with
improvements in anxiety, depression, stress, psychological quality of life and positive affect.
Taken together, the research and personal testimonies raise a broader question: whose voices are
included when decisions about smoking and tobacco harm reduction are made?
For THR Global, people living through these experiences should be part of that conversation.
#WeAreTheEvidence is designed to make lived experience accessible to consumers, researchers,
public-health stakeholders, regulators and the media, allowing decision-makers to understand
smoking and quitting not only through clinical studies and statistics, but through the experiences of
people directly affected.
That call comes as international thinking around tobacco harm reduction continues to evolve. In a
2024 New England Journal of Medicine commentary, Harvard Medical School professor Dr Nancy
Rigotti examined whether evidence around electronic cigarettes as cessation tools had reached a
“tipping point” for the medical and public-health community.
For THR Global, however, the central argument is not that every smoker needs the same solution. It
is that people trying to move away from cigarettes need to be heard.
By putting more than 235 experiences on record, #WeAreTheEvidence is creating a clearer picture of
why people smoke, why quitting can be difficult and what smokers themselves say helped them
move away from cigarettes.
